BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 30094526)

  • 1. Diastolic heart dysfunction is correlated with CTG repeat length in myotonic dystrophy type 1.
    Park JS; Kim N; Park D
    Neurol Sci; 2018 Nov; 39(11):1935-1943. PubMed ID: 30094526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac involvement in a large kindred with myotonic dystrophy. Quantitative assessment and relation to size of CTG repeat expansion.
    Tokgozoglu LS; Ashizawa T; Pacifico A; Armstrong RM; Epstein HF; Zoghbi WA
    JAMA; 1995 Sep; 274(10):813-9. PubMed ID: 7650805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry.
    Chong-Nguyen C; Wahbi K; Algalarrondo V; Bécane HM; Radvanyi-Hoffman H; Arnaud P; Furling D; Lazarus A; Bassez G; Béhin A; Fayssoil A; Laforêt P; Stojkovic T; Eymard B; Duboc D
    Circ Cardiovasc Genet; 2017 Jun; 10(3):. PubMed ID: 28611030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1.
    Logigian EL; Moxley RT; Blood CL; Barbieri CA; Martens WB; Wiegner AW; Thornton CA; Moxley RT
    Neurology; 2004 Apr; 62(7):1081-9. PubMed ID: 15079005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced renal function in patients with Myotonic Dystrophy type 1 and the association to CTG expansion and other potential risk factors for chronic kidney disease.
    Aldenbratt A; Lindberg C; Svensson MK
    Neuromuscul Disord; 2017 Nov; 27(11):1038-1042. PubMed ID: 29029879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fuchs' Endothelial Corneal Dystrophy in Patients With Myotonic Dystrophy, Type 1.
    Winkler NS; Milone M; Martinez-Thompson JM; Raja H; Aleff RA; Patel SV; Fautsch MP; Wieben ED; Baratz KH
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3053-3057. PubMed ID: 30025114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes.
    Overend G; Légaré C; Mathieu J; Bouchard L; Gagnon C; Monckton DG
    Hum Mol Genet; 2019 Jul; 28(13):2245-2254. PubMed ID: 31220271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloride channel dysfunction study in myotonic dystrophy type 1 using repeated short exercise tests.
    Acket B; Lepage B; Maury P; Arne-Bes MC; Cintas P
    Muscle Nerve; 2016 Jun; 54(1):104-9. PubMed ID: 26661627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory failure in a mouse model of myotonic dystrophy does not correlate with the CTG repeat length.
    Panaite PA; Kuntzer T; Gourdon G; Barakat-Walter I
    Respir Physiol Neurobiol; 2013 Oct; 189(1):22-6. PubMed ID: 23811192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual association of a unique CAG interruption in 5' of DM1 CTG repeats with intergenerational contractions and low somatic mosaicism.
    Tomé S; Dandelot E; Dogan C; Bertrand A; Geneviève D; Péréon Y; ; Simon M; Bonnefont JP; Bassez G; Gourdon G
    Hum Mutat; 2018 Jul; 39(7):970-982. PubMed ID: 29664219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of prognosis in type 1 myotonic dystrophy (DM1): longitudinal 18-years experience from a single center.
    Mazzoli M; Ariatti A; Garuti GC; Agnoletto V; Genovese M; Gozzi M; Kaleci S; Marchioni A; Malagoli M; Galassi G
    Acta Myol; 2020 Sep; 39(3):109-120. PubMed ID: 33305167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA).
    DiPaolo G; Jimenez-Moreno C; Nikolenko N; Atalaia A; Monckton DG; Guglieri M; Lochmüller H
    J Neurol; 2017 Apr; 264(4):701-708. PubMed ID: 28168524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy.
    Melacini P; Villanova C; Menegazzo E; Novelli G; Danieli G; Rizzoli G; Fasoli G; Angelini C; Buja G; Miorelli M
    J Am Coll Cardiol; 1995 Jan; 25(1):239-45. PubMed ID: 7798509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length.
    Groh WJ; Lowe MR; Zipes DP
    J Cardiovasc Electrophysiol; 2002 May; 13(5):444-8. PubMed ID: 12030525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between cardiac involvement and CTG repeat amplification in myotonic dystrophy type 1.
    Rakocević-Stojanović V; Savić D; Pavlović S; Lavrnić D; Romac S; Apostolski S
    Acta Myol; 2003 May; 22(1):26-7. PubMed ID: 12966702
    [No Abstract]   [Full Text] [Related]  

  • 16. Heart rate variability declines with increasing age and CTG repeat length in patients with myotonic dystrophy type 1.
    Hardin BA; Lowe MR; Bhakta D; Groh WJ
    Ann Noninvasive Electrocardiol; 2003 Jul; 8(3):227-32. PubMed ID: 14510658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower limb muscle magnetic resonance imaging in myotonic dystrophy type 1 correlates with the six-minute walk test and CTG repeats.
    Park D; Lee SH; Shin JH; Park JS
    Neuromuscul Disord; 2018 Jan; 28(1):29-37. PubMed ID: 29066035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic characteristics of childhood-onset myotonic dystrophy.
    Stokes M; Varughese N; Iannaccone S; Castro D
    Muscle Nerve; 2019 Dec; 60(6):732-738. PubMed ID: 31520483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of cardiac abnormalities and CTG-repeat size in myotonic dystrophy.
    Finsterer J; Gharehbaghi-Schnell E; Stöllberger C; Fheodoroff K; Seiser A
    Clin Genet; 2001 May; 59(5):350-5. PubMed ID: 11359467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CTG-repeat analysis of myotonin protein kinase gene in Bashkortostan patients with myotonic dystrophy].
    Khidiiatova IM; Fatkhlislamova RI; magzhanov RV; Popova SN; Slominskiĭ PA; Limborskaia SA; Khusnutdinova EK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(3):54-8. PubMed ID: 11957350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.